PharmX Technologies (ASX:PHX) confirmed the renewal of its existing exclusive agreement with the National Diabetes Services Scheme (NDSS), with a 24-month extension to the existing arrangement starting July 1, according to a Tuesday Australian bourse filing.
NDSS ordering continues to be one of the most frequent and operationally embedded digital workflows in Australian pharmacies, the filing noted.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.